Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity was posted on August 28, 2013. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Chemicals & Chemical Products / Custom Peptides & Sequences

Closed
NIAID-RFQ-13C-1642842Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

National Institutes of Health, BETHESDA, MD, 20892, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Terry M KnightPurchasing Agent
Tonia L AlexanderContracting Officer

Full Description

Show more
This notice is a combined Synopsis/Solicitation Request for Quote for commercial items prepared in accordance with the format of FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation will not be issued for the solicitation number NIAID-RFQ-13C-1642842, a Request for Quote. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-69 dated August 1, 2013. This acquisition will be processed under Simplified Acquisition Procedures (SAP) and is a small business set-aside. The associated North American Industry Classification System (NAICS) Code is 541711, which has a size standard of 500 employees. The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure custom made peptides sequences. See attached list of peptide name and sequence. Item/Description/ Quantity: (1) Ebola GP (S/B) Carboxyl terminus acid peptides, 5.0mg, 15 amino acids in length, qty-88, and (2) Ebola GP (S/B) Carboxyl terminus acid peptides, 5.0mg, 13 amino acids in length, qty-1. All peptides must meet the requirement with minimum purity of 80%, 1 x 5.0mg = 5mg for each peptide, and HPLC and MS results for each peptide. Place of delivery is to be made to Bethesda, Maryland. The following factors will be used to evaluate offers: 1) capability to meet required salient characteristic specifications, 2) price, and 3) delivery. The FOB point shall be Destination. The Government will issue a firm-fixed price purchase order to the responsible contractor. The following Federal Acquisition Regulations provisions and clauses apply to the acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items; FAR 52.212-2 Evaluation-Commercial Items; Far 52.212-3 Offeror Representation and Certifications Commercial Items; Far 52.212-4 Contract Terms and Conditions Commercial Items; Far 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items; and FAR 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (July 2013). A completed copy of provisions at FAR 52.212-3 Offerors Representation and Certifications Commercial Items must be included which can be found online at System for Award Management (SAM) https://www.sam.gov. By submission of an offer, the Offeror acknowledges the requirement that a prospective awardee shall be registered in the SAM database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. [Note: Lack of registration in SAM will make an Offeror ineligible for award.] All responsible sources may submit offers that will be considered by this agency. Copies of the aforementioned clauses are available upon request by telephone to Terry Knight at (301) 402-2282. Offers must be submitted later than 5:00 p.m. Easter Daylight Savings Time, (EDST), Thursday, September 12, 2013. For delivery through the U.S. Postal Service, the address is NIH/NIAID/AMOB, 10401 Fernwood Road, Room 2NE52E, Bethesda, MD, 20892-4811. E-mail and fax submissions are prohibited.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS